伦敦–(BUSINESS WIRE)–(美国商业资讯)–在世界视力日，Tej Kohli基金会表示，必须专注于新技术，才能加快在全世界终结可治愈角膜失明的全球使命。基金会目前正在资助临床试验和一种“液态生物合成”解决方案的开发，该解决方案有望提供易获取、可扩展且平价的角膜失明解决方案，这种解决方案对于全世界1200万角膜失明患者中的许多人是至关重要的。 Tej Kohli基金会的论点是，人工智能、机器人和基因组学等指数级成长的技术将大幅促进全世界的人道主义努力。基金会的行为类似风投资金，即支持…
Author: Business Wire
Harbour BioMed Announces Completion of Phase 2 Study in China of HBM9036 In Patients With Moderate-to-Severe Dry Eye Disease
CAMBRIDGE, Mass. & ROTTERDAM, The Netherlands & SHANGHAI–(BUSINESS WIRE)–Harbour BioMed Announces Completion of Phase 2 Study in China of HBM9036 in Patients with Moderate-to-Severe Dry Eye Disease
PanOptica Anti-VEGF Eye Drop Shows Promise in Treatment of Neovascular (Wet) AMD
MOUNT ARLINGTON, N.J.–(BUSINESS WIRE)–PanOptica reported positive and unprecedented clinical data for PAN-90806, a once-daily topical eye drop, at OIS@AAO.
Aerpio Pharmaceuticals Announces Interim Results from its Phase 1b Clinical Trial of Topical Ocular Formulation of AKB-9778 for Primary Open Angle Glaucoma
CINCINNATI–(BUSINESS WIRE)–Aerpio Pharmaceuticals, Inc. (Nasdaq:ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, today announced interim results from its Phase …
Ophthalmology Times® Releases 2019 Best Programs Survey Results
CRANBURY, N.J.–(BUSINESS WIRE)– #clinicalprogram–Ophthalmology Times® Releases 2019 Best Programs Survey Results
La Fondation Tej Kohli prône la mise au point d'une solution technologique abordable, accessible et évolutive pour éradiquer la cécité cornéenne dans le monde entier
LONDRES–(BUSINESS WIRE)–En cette journée mondiale de la vue, la Fondation Tej Kohli fait savoir qu’il est nécessaire d’axer les efforts sur les nouvelles technologies afin d’accélérer la mission internationale dont elle s’est investie, consistant à é…
Eyenuk Receives NIH Grant To Expand AI Eye Screening Platform for Neurodegenerative Disease Detection
LOS ANGELES–(BUSINESS WIRE)–Eyenuk Inc. has been awarded a grant to develop a retinal image AI solution for the detection of biomarkers for neurodegenerative disorders.
Compulink Launches E-Commerce Solution for its All-in-One Ophthalmology EHR at AAO 2019
NEWBURY PARK, Calif.–(BUSINESS WIRE)–Compulink launches e-commerce solution for its all-in-one ophthalmology EHR at AAO 2019.
For World Sight Day, Horizon and Prevent Blindness Are Calling on the Thyroid Eye Disease (TED) Community to Put “Vision First”
DUBLIN–(BUSINESS WIRE)–For World Sight Day, Horizon Therapeutics and Prevent Blindness are calling on the thyroid eye disease (TED) community to put “vision first.”
Tej Kohli Foundation engagiert sich für eine skalierbare, zugängliche und erschwingliche Technologielösung zur weltweiten Beseitigung der hornhautbedingten Erblindung
LONDON–(BUSINESS WIRE)–Am Welttag des Sehens (World Sight Day) verkündet die Tej Kohli Foundation, dass ein Fokus auf neue Technologien notwendig ist, um die weltweite Mission zur Beseitigung der hornhautbedingten Erblindung verstärkt verfolgen zu kö…
Fundação Tej Kohli defende uma solução de tecnologia escalável e acessível para acabar com a cegueira corneana no mundo todo
LONDRES–(BUSINESS WIRE)–No Dia Mundial da Visão, a Fundação Tej Kohli afirma que é necessário um foco em novas tecnologias para acelerar a missão global de acabar com a cegueira corneana curável no mundo inteiro. Atualmente, a Fundação está financian…
La Tej Kohli Foundation promuove una soluzione tecnologica scalabile, accessibile e conveniente per eliminare la cecità corneale nel mondo
LONDRA–(BUSINESS WIRE)–In concomitanza con la Giornata mondiale della vista, la Tej Kohli Foundation ha dichiarato che è necessario concentrarsi su nuove tecnologie per accelerare la missione globale che punta a eradicare la cecità corneale curabile …
La Fundación Tej Kohli aboga por una solución tecnológica escalable, accesible y asequible para curar la ceguera corneal en todo el mundo
LONDRES–(BUSINESS WIRE)–En el Día Mundial de la Visión, la Fundación Tej Kohli afirma que es necesario centrarse en las nuevas tecnologías para acelerar la misión mundial de poner fin a la ceguera corneal curable en todo el mundo. Actualmente, la Fun…
Glaukos Achieves Pipeline Milestone with Completion of Patient Enrollment in U.S. IDE Trial for iStent infinite™
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced the c…
Samenvatting: Tej Kohli Foundation pleit voor een schaalbare, toegankelijke en betaalbare technologie-oplossing voor het beëindigen van hoornvliesblindheid wereldwijd
LONDEN–(BUSINESS WIRE)–Op World Sight Day zegt de Tej Kohli Foundation dat er een focus op nieuwe technologieën nodig is om de wereldwijde missie om een einde te maken aan geneesbare corneale blindheid wereldwijd te versnellen. De Stichting financier…
香港国際オプティカルフェアを11月に開催
香港–(BUSINESS WIRE)–（ビジネスワイヤ） — 第27回HKTDC香港国際オプティカルフェアが、2019年11月6～8日に香港会議展覧中心で開催されます。今年の見本市には、約20の国・地域から約800社が出展します。 世界的広がりを見せる第一級の見本市 今年のフェアでは、フランス、イタリア、日本、韓国、台湾、ビジョナリーズ・オブ・スタイル（VOS）、香港中華眼鏡製造廠商会（HKOMA）によるグループ・パビリオンが開設されます。中国本土のパビリオンには、江西省鷹潭市、江蘇省丹陽市、…
Tej Kohli Foundation advocates a scalable, accessible and affordable technology solution to end corneal blindness worldwide.
LONDON–(BUSINESS WIRE)–On World Sight Day, the Tej Kohli Foundation says that a focus on new technologies is needed to accelerate the global mission to end curable corneal blindness worldwide. The Foundation is currently funding the clinical trials a…
Glaukos Products to be Subject of Multiple Presentations at American Academy of Ophthalmology Annual Meeting
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today that …
Kedalion Therapeutics Names New CEO and New Director, Announces Two Promotions, and Will Speak at Ophthalmology Innovation Summit
MENLO PARK, Calif.–(BUSINESS WIRE)–Kedalion Therapeutics names new CEO and new Director, announces two promotions, and will speak at Ophthalmology Innovation Summit
Topcon to Attend American Academy of Ophthalmology 2019 Meeting
OAKLAND, N.J.–(BUSINESS WIRE)– #AAO–Topcon announces new products, OCT Technology Symposium and the debut of Topcon Healthcare during American Academy of Ophthalmology 2019 Meeting.